Your position
The successful candidate will join a highly interdisciplinary research program investigating the role of anti-tumor immunity and therapy response.
Emerging evidence highlights innate immune cells such as neutrophils as key regulators of the tumor microenvironment, capable of both promoting and suppressing anti-tumor immunity. However, the developmental origin, plasticity, and regulatory mechanisms of distinct neutrophil states remain poorly understood.
This project aims to dissect the transcriptional, epigenetic, and metabolic programs that drive antitumoral neutrophil states.
The PhD project will involve:
- Investigation of neutrophil ontogeny and plasticity using murine tumor models and human patient samples
- Application of state-of-the-art single-cell multi-omics
- Functional dissection of key regulatory pathways
- Analysis of immune cell interactions, particularly neutrophil–T cell crosstalk
- Integration of experimental and computational approaches to uncover mechanisms of therapy response and resistance
- The overall goal is to identify novel therapeutic strategies to harness beneficial neutrophil states in cancer immunotherapy.
Selected publications of our lab include:
Zippelius et al., Nat Rev Cancer 2025; Schmid et al., Nat Comm 2025; Fusi et al., Sci Transl Med 2025; Tundo et al., JITC 2024; Fernandez-Rodriguez et al., JITC 2023; Trefny et al, Nat Comm 2023; Kirchhammer et al., Sci Transl Med 2022; among others.